Neurocrine Biosciences, Inc. · San Diego, CA United States ·(NASDAQ (GS): NBIX)
Company Description
View Neurocrine Biosciences, Inc. Locations On A US Map
This link will open in a new window
For Neurocrine Biosciences, biology is all chemistry. The development-stage biotech develops treatments for neurological and endocrine-related diseases, such as insomnia, depression, and pain. Lead drug candidate Indiplon aims to treat insomnia; the company acquired the rights to Indiplon from DOV Pharmaceutical but has had difficulty winning FDA approval for the drug. Neurocrine Biosciences is also developing treatments for anxiety, depression, and irritable bowel syndrome with GlaxoSmithKline ; it has other development programs for endometriosis, congestive heart failure, and enlarged prostate. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Neurocrine Biosciences, Inc. Financials
| Company Type | Public - NASDAQ (GS): NBIX Single Location |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $4.0 |
| 2008 Employees | 125 |
Neurocrine Biosciences, Inc. Executives
15 executives listed for Neurocrine Biosciences, Inc.'s San Diego, CA location.
| Title | Name & Bio | Contact |
| Chairman | Joseph Mollica | Network |
| President, CEO, and Director | Kevin Gorman | Network |
| VP and CFO | Timothy Coughlin | Network |
Competition
Competitive Landscape for Neurocrine Biosciences, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Neurocrine Biosciences, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
